Therapeutic angiogenesis of critical lower limb ischemia. Literature review and research perspective on stem cells;Angiogenesi terapeutica nell'ischemia critica degli arti inferiori. Revisione della letteratura e prospettive della ricerca sulle cellule staminali

Italian Heart Journal, Supplementi

Volumn 5, Issue 1, 2004, Pages 1-13

  Di Stefano, Rossella ^a   Limbruno, Ugo ^a   Barone, Daniele ^a   Balbarini, Alberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Angiogenesis; Cells; Ischemia

Indexed keywords

VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; CLINICAL TRIAL; CRITICAL ILLNESS; HUMAN; ISCHEMIA; LEG; MEDICAL RESEARCH; PHYSIOLOGY; REVIEW; STEM CELL TRANSPLANTATION; VASCULARIZATION;

ANIMALS; BIOMEDICAL RESEARCH; CLINICAL TRIALS; CRITICAL ILLNESS; HUMANS; ISCHEMIA; LEG; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16644383319     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (111)

1. Hockel M, Schlenger K, Doctrow S, Kissel T, Vaupel P. Therapeutic angiogenesis. Arch Surg 1993; 128: 423-9.
2. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31 (Part 2): S1-S296.
3. Second European Consensus Document on chronic critical leg ischemia. Circulation 1991; 84 (Suppl): IV1-IV26.
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25. (Pubitemid 27076453)
5. Engler DA. Use of vascular endothelial growth factor for therapeutic angiogenesis. Circulation 1996; 94: 1496-8.
6. Schaper W. Control of coronary angiogenesis. Eur Heart J 1995; 16 (Suppl C): 66-8.
7. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11: 73-91.
8. Ribatti D, Vacca A, Vico B, Roncalli L, Dammacco F. Postnatal vasculogenesis. Mech Dev 2001; 100: 157-63.
9. Beck L Jr, D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J 1997; 11: 365-73.
10. Tabibiazar R, Rockson SG. Angiogenesis and the ischaemic heart. Eur Heart J 2001; 22: 903-18.
11. Kumar S, West D, Shahabuddin S, et al. Angiogenesis factor from human myocardial infarcts. Lancet 1983; 2: 364-8. (Pubitemid 13028930)
12. Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996; 93: 2576-81.
13. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997; 276: 1423-5.
14. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87: 3336-43. (Pubitemid 26115364)
15. Millauer B, Wizigmann-Voos S, Schnurch H, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-46.
16. Liu B, Earl HM, Baban D, et al. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem Biophys Res Commun 1995; 217: 721-7.
17. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-8.
18. Van Der Zee R, Murohara T, Luo Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997; 95: 1030-7.
19. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153: 557-62.
20. Namiki A, Brogi E, Kearney M, et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995; 52: 31189-95. (Pubitemid 26012206)
21. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995; 92: 768-72.
22. Ledoux D, Gannoun-Zaki L, Barritault D. Interactions of FGFs with target cells. Prog Growth Factor Res 1992; 4: 107-20.
23. Xu X, Weinstein M, Li C, Deng C. Fibroblast growth factor receptors (FGFRs) and their roles in limb development. Cell Tissue Res 1999; 296: 33-43. (Pubitemid 29179370)
24. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell 1996; 27: 1153-5.
25. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993; 69: 508-17. (Pubitemid 24004487)
26. Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995; 92 (Suppl): II365-II371.
27. Kuwabara K, Ogawa S, Matsumoto M, et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci USA 1995; 92: 4606-10.
28. Fujita M, Ikemoto M, Kishishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996; 94: 610-3. (Pubitemid 26289212)
29. Engelmann GL, Dionne CA, Jaye MC. Acidic fibroblast growth factor and heart development. Role in myocyte proliferation and capillary angiogenesis. Circ Res 1993; 72: 7-19
30. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-80. (Pubitemid 27010101)
31. Martins RN, Chleboun JO, Sellers P, Sleigh M, Muir J. The role of PDGF-BB on the development of the collateral circulation after acute arterial occlusion. Growth Factors 1994; 10: 299-306. (Pubitemid 24254254)
32. Van Belle E, Witzenbichler B, Chen D, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998; 97: 381-90. (Pubitemid 28074339)
33. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997; 80: 829-37. (Pubitemid 27230057)
34. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine- induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-8.
35. Vincent KA, Shyu KG, Luo Y, et al. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 2000; 102: 2255-61.
36. Emanueli C, Zacheo A, Minasi A, et al. Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle. Arterioscler Thromb Vasc Biol 2000; 20: 2379-85.
37. Emanueli C, Minasi A, Zacheo A, et al. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation 2001; 103: 125-32.
38. Kyriakides ZS, Petinakis P, Kaklamanis L, et al. Intramuscular administration of estrogen may promote angiogenesis and perfusion in a rabbit model of chronic limb ischemia. Cardiovasc Res 2001; 49: 626-33. (Pubitemid 32146426)
39. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995; 95: 1798-807.
40. Schultz A, Lavie L, Hochberg I, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999; 100: 547-52. (Pubitemid 29360165)
41. Morris PB, Ellis MN, Swain JL. Angiogenic potency of nucleotide metabolites: potential role in ischemia-induced vascular growth. J Mol Cell Cardiol 1989; 21: 351-8.
42. Sunderkotter C, Beil W, Roth J, Sorg C. Cellular events associated with inflammatory angiogenesis in the mouse cornea. Am J Pathol 1991; 138: 931-9.
43. Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther 1991; 51: 195-216.
44. Polverini PJ. Cellular adhesion molecules. Newly identified mediators of angiogenesis. Am J Pathol 1996; 148: 1023-9.
45. Ando J, Nomura H, Kamiya A. The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells. Microvasc Res 1987; 33: 62-70. (Pubitemid 17006443)
46. Li J, Hampton T, Morgan JP, Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest 1997; 100: 18-24.
47. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8. (Pubitemid 29377293)
48. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-9.
49. Ikenaga S, Hamano K, Nishida M, et al. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J Surg Res 2001; 96: 277-83. (Pubitemid 34969444)
50. Hamano K, Li TS, Kobayashi T, et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery 2001; 130: 44-54. (Pubitemid 32626197)
51. Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103: 897-903. (Pubitemid 32163891)
52. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7. (Pubitemid 27087709)
53. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-7. (Pubitemid 30183318)
54. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-36. (Pubitemid 30390303)
55. Kobayashi T, Hamano K, Li TS, et al. Angiogenesis induced by the injection of peripheral leukocytes and platelets. J Surg Res 2002; 103: 279-86. (Pubitemid 34948513)
56. Iba O, Matsubara H, Nozawa Y. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002; 106: 2019-25. (Pubitemid 35176311)
57. Bauters C, Asahara T, Zheng LP, et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 1995; 91: 2802-9.
58. Bauters C, Asahara T, Zheng LP, et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 1995; 21: 314-24.
59. Takeshita S, Tsurumi Y, Couffinahl T, et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 1996; 75: 487-501. (Pubitemid 26346800)
60. Takeshita S, Weir L, Chen D, et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun 1996; 227: 628-35. (Pubitemid 26362853)
61. Tsurumi Y, Kearney M, Chen D, et al. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 1997; 96 (Suppl): II382-II388.
62. Takeshita S, Isshiki T, Ochiai M, et al. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 1998; 98: 1261-3. (Pubitemid 28443387)
63. Mack CA, Magovern CJ, Budenbender KT, et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg 1998; 27: 699-709. (Pubitemid 28201761)
64. Vajanto I, Rissanen TT, Rutanen J, et al. Effects of intramuscular adenovirus mediated vascular endothelial growth factor (VEGF) gene transfer to rabbit ischemic hindlimb. (abstr) J Gen Med 2000; 2 (Suppl): 76.
65. Pu LQ, Gadowski GR, Graham AM, et al. Enhanced revascularisation after angiogenic stimulation in a rabbit model of bilateral limb ischaemia. Eur J Vasc Endovasc Surg 1995; 9: 189-96.
66. Chleboun JO, Martins RN, Mitchell CA, Chirila TV. bFGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem Biophys Res Commun 1992; 185: 510-6.
67. Garcia-Martinez C, Opolon P, Trochon V, et al. Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor. Gene Ther 1999; 6: 1210-21. (Pubitemid 29359014)
68. Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998; 98: 2081-7. (Pubitemid 28512235)
69. Chae JK, Kim I, Lim ST, et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 2000; 20: 2573-8.
70. Bauters C, Asahara T, Zheng LP, et al. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol 1994; 267 (Part 2): H1263-H1271. (Pubitemid 24327906)
71. Takeshita S, Rossow ST, Kearney M, et al. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 1995; 147: 1649-60.
72. Walder CE, Errett CJ, Bunting S, et al. Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia. J Cardiovasc Pharmacol 1996; 27: 91-8. (Pubitemid 26010645)
73. Hopkins SP, Bulgrin JP, Sims RL, Bowman B, Donovan DL, Schmidt SP. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia. J Vasc Surg 1998; 27: 886-94.
74. Takeshita S, Pu LQ, Stein LA, et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994; 90 (Part 2): II228-II234.
75. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998; 2: 549-58. (Pubitemid 128379081)
76. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111-20.
77. 121 gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 2000; 102: 565-71.
78. Gowdak LH, Poliakova L, Li Z, Grove R, Lakatta EG, Talan M. Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model. J Vasc Surg 2000; 32: 343-52. (Pubitemid 30644949)
79. Witzenbichler B, Asahara T, Murohara T, et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998; 153: 381-94.
80. Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94: 3281-90.
81. Messina LM, Brevetti LS, Chang DS, Paek R, Sarkar R. Therapeutic angiogenesis for critical limb ischemia: invited commentary. J Control Release 2002; 78: 285-94. (Pubitemid 34081873)
82. Nabel EG, Yang ZY, Plautz G, et al. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993; 362: 844-6.
83. Muhlhauser J, Pili R, Merrill MJ, et al. In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor. Hum Gene Ther 1995; 6: 1457-65.
84. Rosengart TK, Budenbender KT, Duenas M, Mack CA, Zhang QX, Isom OW. Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin. J Vasc Surg 1997; 26: 302-12. (Pubitemid 27362668)
85. Pu LQ, Snidermann AD, Brassard R, et al. Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 1993; 88: 208-15. (Pubitemid 23195451)
86. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992; 16: 181-91.
87. Yang HT, Deschenes MR, Ogilvie RW, Terjung RL. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res 1996; 79: 62-9.
88. Jejurikar SS, Welling TH, Zelenock JA, et al. Induction of angiogenesis by lidocaine and basic fibroblast growth factor: a model for in vivo retroviral-mediated gene therapy. J Surg Res 1997; 67: 137-46.
89. Stark J, Baffour R, Garb JL, et al. Basic fibroblast growth factor stimulates angiogenesis in the hindlimb of hyperglycemic rats. J Surg Res 1998; 79: 8-12.
90. Bush RL, Pevec WC, Ndoye A, Cheung AT, Sasse J, Pearson DN. Regulation of new blood vessel growth into ischemic skeletal muscle. J Vasc Surg 1998; 28: 919-28. (Pubitemid 28521033)
91. Baffour R, Garb JL, Kaufman J, et al. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res 2000; 93: 219-29.
92. Yang HT, Feng Y, Allen LA, Protter A, Terjung RL. Efficacy and specificity of bFGF increased collateral flow in experimental peripheral arterial insufficiency. Am J Physiol 2000; 278: H1966-H1973. (Pubitemid 30439210)
93. Yang HT, Feng Y. bFGF increases collateral blood flow in aged rats with femoral artery ligation. Am J Physiol 2000; 278: H85-H93.
94. Tabata H, Silver M, Isner JM. Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA. Cardiovasc Res 1997; 35: 470-9. (Pubitemid 27469408)
95. Ueno H, Li JJ, Masuda S, Qi Z, Yamamoto H, Takeshita A. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 1997; 17: 2453-60. (Pubitemid 28015981)
96. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-4.
97. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow- derived endothelial progenitor cells. EMBO J 1999; 18: 3964-72. (Pubitemid 29335849)
98. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-23.
99. Isner JM, Baumgartner I, Rauh G, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 1998; 28: 964-73.
100. Rissanen TT, Vajanto I, Yla-Herttuala S. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic. Eur J Clin Invest 2001; 31: 651-66. (Pubitemid 32756613)
101. Lederman RJ, Mendelsohn FO, Anderson RD, et al, for the TRAFFIC Investigators. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 2002; 359: 2053-8.
102. Shyu KG, Chang H, Wang BW, Kuan P. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am J Med 2003; 114: 85-92. (Pubitemid 36183588)
103. Tateishi-Yuyama E, Matsubara H, Murohara T, et al, for the Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-35.
104. Minamino T, Toko H, Tateno K, Nagai T, Komuro I. Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? (letter) Lancet 2002; 360: 2083-4.
105. Inaba S, Egashira K, Komori K. Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? (letter) Lancet 2002; 360: 2083.
106. Baumgartner I. Intramuscular vascular endothelial growth factor gene therapy: fact or fiction? Am J Med 2003; 114: 156-7.
107. Grosskreutz CL, Anand-Apte B, Duplaa C, et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 1999; 58: 128-36. (Pubitemid 29419938)
108. Laitinen M, Zachary I, Breier G, et al. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 1997; 8: 1737-44. (Pubitemid 27488923)
109. Kroll J, Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 1998; 252: 743-6. (Pubitemid 28556847)
110. Di Stefano R, Santoni T, Barsotti MC, et al. Different growth conditions for peripheral blood endothelial progenitors. Cardiovasc Radiat Med 2002; 3: 172-5.
111. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.